Experience in the Use of an Immunomodulator in the Complex Treatment of Patients with Resistant Forms of Paranoid Schizophrenia

dc.creatorMurodullayevich, Kubayev Rustam
dc.date2023-08-08
dc.date.accessioned2023-08-21T09:05:16Z
dc.date.available2023-08-21T09:05:16Z
dc.descriptionThe problem of therapeutic (medical) resistance is quite complex and relevant. The emergence of new antipsychotic drugs, as well as special methods designed to affect resistance, the number of patients who do not respond to drugs remains constant and is 30%.en-US
dc.formatapplication/pdf
dc.identifierhttps://univerpubl.com/index.php/scholastic/article/view/2455
dc.identifier.urihttp://dspace.umsida.ac.id/handle/123456789/22136
dc.languageeng
dc.publisherUniver Publishingen-US
dc.relationhttps://univerpubl.com/index.php/scholastic/article/view/2455/2114
dc.sourceScholastic: Journal of Natural and Medical Education; Vol. 2 No. 8 (2023): Scholastic: Journal of Natural and Medical Education; 62-67en-US
dc.subjectschizophreniaen-US
dc.subjectforms of paranoiden-US
dc.subjectimmunomodulatoren-US
dc.subjectantipsychoticen-US
dc.titleExperience in the Use of an Immunomodulator in the Complex Treatment of Patients with Resistant Forms of Paranoid Schizophreniaen-US
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Articleen-US
Files